Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yimin Yu

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Nanomedicine|November 13, 2024
Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice ModelAng Li, Xushan Cai, Dong Li, et al.
Neuropsychiatric Disease and Treatment|March 23, 2018
Analysis of the association of <i>MIR124-1</i> and its target gene <i>RGS4</i> polymorphisms with major depressive disorder and antidepressant responseDuan Zeng, Shen He, Shunying Yu, et al.
Expert Opinion on Investigational Drugs|December 6, 2023
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administrationYimin Yu, Jingjing He, Zhiwei Huang, et al.
Brain, Behavior, and Immunity|February 25, 2026
Multi-omics integration of inflammation, immunity, and metabolism identifies depression subtypes associated with treatment responseDuan Zeng, Yuzhen Zheng, Xue Zhao, et al.
Journal of Affective Disorders|July 14, 2019
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trialYifeng Shen, Qian Zhao, Yimin Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Flagellin is the major proinflammatory determinant of enteropathogenic SalmonellaHui Zeng, Adam Q Carlson, Yanwen Guo, et al.
Frontiers in Pharmacology|June 30, 2022
Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up "Real World" Study in ChinaLei Zhang, Sidi He, Luyao He, et al.
Frontiers in Genetics|August 21, 2019
Co-Expression Network Analysis Revealed That the <i>ATP5G1</i> Gene Is Associated With Major Depressive DisorderDuan Zeng, Shen He, Changlin Ma, et al.
Materials Today. Bio|July 18, 2025
A novel fertility-sparing nanocomposite for endometriosis treatment via oxidative stress and inflammation alleviationWenwen Liu, Jie Shen, Jiaqi You, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in SchizophreniaZhiwei Huang, Lei Zhang, Yan Li, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Nanomedicine|November 13, 2024
Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice ModelAng Li, Xushan Cai, Dong Li, et al.
Neuropsychiatric Disease and Treatment|March 23, 2018
Analysis of the association of <i>MIR124-1</i> and its target gene <i>RGS4</i> polymorphisms with major depressive disorder and antidepressant responseDuan Zeng, Shen He, Shunying Yu, et al.
Expert Opinion on Investigational Drugs|December 6, 2023
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administrationYimin Yu, Jingjing He, Zhiwei Huang, et al.
Brain, Behavior, and Immunity|February 25, 2026
Multi-omics integration of inflammation, immunity, and metabolism identifies depression subtypes associated with treatment responseDuan Zeng, Yuzhen Zheng, Xue Zhao, et al.
Journal of Affective Disorders|July 14, 2019
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trialYifeng Shen, Qian Zhao, Yimin Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Flagellin is the major proinflammatory determinant of enteropathogenic SalmonellaHui Zeng, Adam Q Carlson, Yanwen Guo, et al.
Frontiers in Pharmacology|June 30, 2022
Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up "Real World" Study in ChinaLei Zhang, Sidi He, Luyao He, et al.
Frontiers in Genetics|August 21, 2019
Co-Expression Network Analysis Revealed That the <i>ATP5G1</i> Gene Is Associated With Major Depressive DisorderDuan Zeng, Shen He, Changlin Ma, et al.
Materials Today. Bio|July 18, 2025
A novel fertility-sparing nanocomposite for endometriosis treatment via oxidative stress and inflammation alleviationWenwen Liu, Jie Shen, Jiaqi You, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in SchizophreniaZhiwei Huang, Lei Zhang, Yan Li, et al.
Pageof 5